Loading
companiesCompany
Alexandria Venture Investments
Alexandria Venture Investments is the venture arm of Alexandria Real Estate Equities, the life science property company, and takes small, non-lead stakes across a large number of biotech start-ups, often tenants of its campuses, in oncology and other areas. Its web pages blocked automated access, so its own strategy and named cancer companies are unconfirmed.
Overview
Alexandria Venture Investments is the strategic venture capital platform of Alexandria Real Estate Equities, Inc. (NYSE: ARE), the Pasadena-based life science real estate investment trust founded in January 1994 by Joel Marcus and Jerry Sudarsky (Wikipedia). The venture arm invests small, non-lead amounts across a large number of life science companies, many of them tenants of Alexandria campuses, spanning oncology and other therapeutic areas. The are.com venture pages returned an empty body or an Incapsula 'Request unsuccessful' block on every fetch attempt, so the platform's own description, founding year, strategy and named oncology portfolio companies could not be confirmed from a primary source.
Portfolio (5)
Filter the startups table| Company | Stage | Type | Cancers | Latest round |
|---|---|---|---|---|
| Dantari Thousand Oaks, CA, US | Wound down | biotech | HR-positive / HER2-negative breast cancerTriple-negative breast cancer (TNBC) | Series A 2022, $47M |
| Enlaza Therapeutics La Jolla, CA, US | Startup | biotech | Series A 2024, $100M | |
| Immunai New York, NY, US | Growth stage | ai software | none on record | |
| Neomorph San Diego, CA, US | Startup | biotech | Renal cell carcinoma | Series B 2026, $100M |
| Stablix New York, NY, US | Startup | biotech | Series A 2021, $63M |
Notes
top- Page fetched on 2026-09-10; founded year is the parent company's.
Similar pages
- CompanyAmgen Ventures
Shares Enlaza Therapeutics and the tag corporate-venture.